ASX - By Stock
|
RGT |
Re:
The rotting remains of MGC Pharmaceuticals (MXC).
|
|
bluey10
|
9 |
2.6K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
9
|
2.6K
|
4
|
|
ASX - By Stock
|
XTC |
Re:
Ann: Continuation of Suspension from Quotation
|
|
bluey10
|
41 |
22K |
2 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
41
|
22K
|
2
|
|
ASX - By Stock
|
XTC |
Re:
Ann: Quarterly Activities Report Dec 2023
|
|
bluey10
|
27 |
10K |
7 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
27
|
10K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
bluey10
|
8 |
2.7K |
2 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
8
|
2.7K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Notification regarding unquoted securities - MXC
|
|
bluey10
|
2 |
1.4K |
2 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
2
|
1.4K
|
2
|
|
ASX - By Stock
|
XTC |
Re:
bad news
|
|
bluey10
|
4 |
1.6K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
4
|
1.6K
|
1
|
|
ASX - By Stock
|
XTC |
Re:
good news
|
|
bluey10
|
174 |
76K |
1 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
174
|
76K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Secures US$7.9 Million in Firm Commitments
|
|
bluey10
|
20 |
7.3K |
2 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
20
|
7.3K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
News: MXC MGC Pharmaceuticals Seeks Trading Halt
|
|
bluey10
|
1 |
386 |
3 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
1
|
386
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Preliminary Final Report
|
|
bluey10
|
7 |
1.7K |
3 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
7
|
1.7K
|
3
|
|
ASX - By Stock
|
XTC |
Re:
Ann: Capital Consolidation - Appointment of Capita Market Advisor
|
|
bluey10
|
86 |
30K |
6 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
86
|
30K
|
6
|
|
ASX - By Stock
|
XTC |
Re:
XTC General discussion
|
|
bluey10
|
2.5K |
1.0M |
4 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
XTC |
Re:
XTC General discussion
|
|
bluey10
|
2.5K |
1.0M |
2 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
RGT |
What's going on?
|
|
bluey10
|
5 |
3.0K |
2 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
5
|
3.0K
|
2
|
|
ASX - By Stock
|
XTC |
Re:
XTC General discussion
|
|
bluey10
|
2.5K |
1.0M |
2 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
bluey10
|
12 |
3.2K |
2 |
29/04/23 |
29/04/23 |
ASX - By Stock
|
12
|
3.2K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
bluey10
|
12 |
3.2K |
4 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
12
|
3.2K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Application for quotation of securities - MXC
|
|
bluey10
|
2 |
772 |
5 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
2
|
772
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Receive Permission for Psilocybin Research & Development
|
|
bluey10
|
6 |
2.2K |
5 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
6
|
2.2K
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Notification of cessation of securities - MXC
|
|
bluey10
|
2 |
1.1K |
4 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
2
|
1.1K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
News: MXC Mgc Pharmaceuticals Says Artemic Listed As Otc Drug In Usa
|
|
bluey10
|
1 |
378 |
2 |
21/03/23 |
21/03/23 |
ASX - By Stock
|
1
|
378
|
2
|
|
ASX - By Stock
|
XTC |
Re:
options
|
|
bluey10
|
2 |
1.1K |
1 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
2
|
1.1K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Half Year Accounts
|
|
bluey10
|
2 |
874 |
0 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
2
|
874
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Notification regarding unquoted securities - MXC
|
|
bluey10
|
4 |
1.1K |
6 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
4
|
1.1K
|
6
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Provision of US$600,000 Funding and change of CFO
|
|
bluey10
|
7 |
2.1K |
6 |
04/02/23 |
04/02/23 |
ASX - By Stock
|
7
|
2.1K
|
6
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Provision of US$600,000 Funding and change of CFO
|
|
bluey10
|
7 |
2.1K |
4 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
7
|
2.1K
|
4
|
|
ASX - By Stock
|
XTC |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
bluey10
|
6 |
2.9K |
8 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
6
|
2.9K
|
8
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
bluey10
|
11 |
3.5K |
2 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
11
|
3.5K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Results of CimetrA bioanalytics pre-clinal trial
|
|
bluey10
|
22 |
6.8K |
9 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
22
|
6.8K
|
9
|
|
ASX - By Stock
|
BCN |
Re:
Ann: Geko Tenements Acquired
|
|
bluey10
|
52 |
15K |
0 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
52
|
15K
|
0
|
|
ASX - By Stock
|
XTC |
Re:
XTC outstanding shares
|
|
bluey10
|
41 |
15K |
4 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
41
|
15K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Completion of CimetrA Efficacy Pre-clinical Trial
|
|
bluey10
|
4 |
1.4K |
1 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
4
|
1.4K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Publication of Peer Reviewed Glioblastoma Research
|
|
bluey10
|
2 |
1.0K |
1 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
2
|
1.0K
|
1
|
|
ASX - By Stock
|
XTC |
Re:
XTC General discussion
|
|
bluey10
|
2.5K |
1.0M |
5 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
2.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Outlook for MXC
|
|
bluey10
|
306 |
151K |
4 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
306
|
151K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Outlook for MXC
|
|
bluey10
|
306 |
151K |
3 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
306
|
151K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Outlook for MXC
|
|
bluey10
|
306 |
151K |
5 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
306
|
151K
|
5
|
|
ASX - By Stock
|
XTC |
Re:
XTC General discussion
|
|
bluey10
|
2.5K |
1.0M |
5 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
2.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
XTC |
Re:
XTC General discussion
|
|
bluey10
|
2.5K |
1.0M |
0 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
2.5K
|
1.0M
|
0
|
|
ASX - By Stock
|
TPD |
Re:
Ann: Trading Halt
|
|
bluey10
|
74 |
35K |
3 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
74
|
35K
|
3
|
|
ASX - By Stock
|
XTC |
Re:
XTC next LKE???
|
|
bluey10
|
757 |
363K |
1 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
757
|
363K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Sciensus Rare EU & UK Sales and Distribution Agreement
|
|
bluey10
|
10 |
3.5K |
4 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
10
|
3.5K
|
4
|
|
ASX - By Stock
|
BCN |
Re:
Ann: Beacon Enters into Forward Gold Sales at $2,715 per Ounce
|
|
bluey10
|
112 |
31K |
6 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
112
|
31K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives FDA feedback for Efti development in MBC
|
|
bluey10
|
43 |
21K |
5 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
43
|
21K
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
bluey10
|
74 |
23K |
7 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
74
|
23K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bluey10
|
2.6K |
1.0M |
3 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: UK Capital Raising Completed
|
|
bluey10
|
3 |
1.8K |
2 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
3
|
1.8K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: ArtemiC receives Indian importation and sales approval
|
|
bluey10
|
12 |
5.3K |
2 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
12
|
5.3K
|
2
|
|
ASX - By Stock
|
XTC |
Re:
Ann: Option Agreement to Acquire Further Lithium Brine Tenements
|
|
bluey10
|
129 |
56K |
7 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
129
|
56K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: ArtemiC Long COVID Syndrome Clinical Study Commenced
|
|
bluey10
|
6 |
3.7K |
5 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
6
|
3.7K
|
5
|
|